CATX Perspective Therapeutics
- 14.9800
- +0.8000+5.64%
Perspective Therapeutics News
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 424B5: Prospectus
Perspective Therapeutics | 10-Q: Q2 2024 Earnings Report
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 8-K/A: Current report (Amendment)
Perspective Therapeutics | 8-K: Current report
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Austin Mark John
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Williamson Robert F III
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENSON HEIDI
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morich Frank
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Woods Lori A
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Spoor Johan M.
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Puhlmann Markus
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hunt Jonathan Robert
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hunt Jonathan Robert
Perspective Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Woods Lori A
Analysis
Price Target
No Data
